rs1063125

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000702.4(ATP1A2):​c.1119G>A​(p.Ser373=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.194 in 1,613,918 control chromosomes in the GnomAD database, including 31,710 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.19 ( 2807 hom., cov: 31)
Exomes 𝑓: 0.19 ( 28903 hom. )

Consequence

ATP1A2
NM_000702.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: -6.55
Variant links:
Genes affected
ATP1A2 (HGNC:800): (ATPase Na+/K+ transporting subunit alpha 2) The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of Na+/K+ -ATPases. Na+/K+ -ATPase is an integral membrane protein responsible for establishing and maintaining the electrochemical gradients of Na and K ions across the plasma membrane. These gradients are essential for osmoregulation, for sodium-coupled transport of a variety of organic and inorganic molecules, and for electrical excitability of nerve and muscle. This enzyme is composed of two subunits, a large catalytic subunit (alpha) and a smaller glycoprotein subunit (beta). The catalytic subunit of Na+/K+ -ATPase is encoded by multiple genes. This gene encodes an alpha 2 subunit. Mutations in this gene result in familial basilar or hemiplegic migraines, and in a rare syndrome known as alternating hemiplegia of childhood. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 1-160128753-G-A is Benign according to our data. Variant chr1-160128753-G-A is described in ClinVar as [Benign]. Clinvar id is 128477.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-160128753-G-A is described in Lovd as [Benign]. Variant chr1-160128753-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-6.55 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.314 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ATP1A2NM_000702.4 linkuse as main transcriptc.1119G>A p.Ser373= synonymous_variant 9/23 ENST00000361216.8 NP_000693.1
ATP1A2XM_047421286.1 linkuse as main transcriptc.228G>A p.Ser76= synonymous_variant 2/16 XP_047277242.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ATP1A2ENST00000361216.8 linkuse as main transcriptc.1119G>A p.Ser373= synonymous_variant 9/231 NM_000702.4 ENSP00000354490 P1
ATP1A2ENST00000392233.7 linkuse as main transcriptc.1119G>A p.Ser373= synonymous_variant 9/235 ENSP00000376066
ATP1A2ENST00000447527.1 linkuse as main transcriptc.252G>A p.Ser84= synonymous_variant 2/162 ENSP00000411705
ATP1A2ENST00000472488.5 linkuse as main transcriptn.1222G>A non_coding_transcript_exon_variant 9/202

Frequencies

GnomAD3 genomes
AF:
0.188
AC:
28522
AN:
151908
Hom.:
2798
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.192
Gnomad AMI
AF:
0.237
Gnomad AMR
AF:
0.141
Gnomad ASJ
AF:
0.181
Gnomad EAS
AF:
0.159
Gnomad SAS
AF:
0.328
Gnomad FIN
AF:
0.139
Gnomad MID
AF:
0.196
Gnomad NFE
AF:
0.195
Gnomad OTH
AF:
0.200
GnomAD3 exomes
AF:
0.190
AC:
47782
AN:
251460
Hom.:
5136
AF XY:
0.199
AC XY:
27101
AN XY:
135908
show subpopulations
Gnomad AFR exome
AF:
0.186
Gnomad AMR exome
AF:
0.0890
Gnomad ASJ exome
AF:
0.178
Gnomad EAS exome
AF:
0.160
Gnomad SAS exome
AF:
0.324
Gnomad FIN exome
AF:
0.141
Gnomad NFE exome
AF:
0.200
Gnomad OTH exome
AF:
0.197
GnomAD4 exome
AF:
0.195
AC:
284353
AN:
1461892
Hom.:
28903
Cov.:
35
AF XY:
0.199
AC XY:
144823
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.188
Gnomad4 AMR exome
AF:
0.0934
Gnomad4 ASJ exome
AF:
0.178
Gnomad4 EAS exome
AF:
0.195
Gnomad4 SAS exome
AF:
0.317
Gnomad4 FIN exome
AF:
0.141
Gnomad4 NFE exome
AF:
0.192
Gnomad4 OTH exome
AF:
0.194
GnomAD4 genome
AF:
0.188
AC:
28552
AN:
152026
Hom.:
2807
Cov.:
31
AF XY:
0.187
AC XY:
13905
AN XY:
74318
show subpopulations
Gnomad4 AFR
AF:
0.192
Gnomad4 AMR
AF:
0.141
Gnomad4 ASJ
AF:
0.181
Gnomad4 EAS
AF:
0.160
Gnomad4 SAS
AF:
0.327
Gnomad4 FIN
AF:
0.139
Gnomad4 NFE
AF:
0.195
Gnomad4 OTH
AF:
0.198
Alfa
AF:
0.173
Hom.:
1054
Bravo
AF:
0.182
EpiCase
AF:
0.200
EpiControl
AF:
0.204

ClinVar

Significance: Benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJul 31, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 22% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 20. Only high quality variants are reported. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 04, 2014- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 07, 2017- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Migraine, familial hemiplegic, 2 Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabDec 05, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Alternating hemiplegia of childhood 1 Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 09, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabDec 05, 2021- -
Developmental and epileptic encephalopathy 98 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabDec 05, 2021- -
Familial hemiplegic migraine Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.8
DANN
Benign
0.81

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1063125; hg19: chr1-160098543; COSMIC: COSV63402896; COSMIC: COSV63402896; API